Aslanov A S, Lavretskaia G I
Probl Endokrinol (Mosk). 1987 Jul-Aug;33(4):51-5.
The paper is concerned with the results of an experimental and clinical study of the hypothalamus-releasing hormone (TRH, rifathyroin). TRH was shown to possess a peculiar spectrum of stimulating action bringing it nearer to such psychotropic agents as psychostimulants and antidepressants. In experiments on animals TRH increased locomotivity without induction of aggression, stereotypia, epileptic disorders, enhanced the effects of amphetamine, apomorphine, L-DOPA, reduced the action of reserpine, haloperidol, and clonidine. TRH facilitated the teaching of rats in a T-form labyrinth causing rotating behavior of rats during administration in the caudate nucleus head. Experimental data indicated the presence of adreno- and dopaminestimulating properties in TRH. Euphoristic and stimulating effects were noted in clinical application of TRH as a diagnostic agent in 42 patients with depressive disturbances.
本文涉及下丘脑释放激素(促甲状腺激素释放激素,替鲁噻吨)的实验和临床研究结果。促甲状腺激素释放激素显示出具有独特的刺激作用谱,使其更接近精神兴奋药和抗抑郁药等精神药物。在动物实验中,促甲状腺激素释放激素增加了运动能力,而未诱发攻击行为、刻板行为、癫痫发作,增强了苯丙胺、阿扑吗啡、左旋多巴的作用,减弱了利血平、氟哌啶醇和可乐定的作用。促甲状腺激素释放激素促进大鼠在T形迷宫中的学习,在向尾状核头部给药期间导致大鼠出现旋转行为。实验数据表明促甲状腺激素释放激素具有刺激肾上腺素能和多巴胺能的特性。在42例抑郁障碍患者中,促甲状腺激素释放激素作为诊断剂的临床应用中观察到了欣快和刺激作用。